Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials

Lalitha K. Shankar, John M. Hoffman, Steve Bacharach, Michael M. Graham, Joel Karp, Adriaan A. Lammertsma, Steven Larson, David A. Mankoff, Barry A. Siegel, Annick Van Den Abbeele, Jeffrey Yap, Daniel Sullivan

Research output: Contribution to journalArticlepeer-review

593 Scopus citations
Original languageEnglish
Pages (from-to)1059-1066
Number of pages8
JournalJournal of Nuclear Medicine
Volume47
Issue number6
StatePublished - 2006

Cite this